Hypersecretion of luteinizing hormone and the polycystic ovary syndrome

Human Reproduction

Volumn 8, Issue , 1993, Pages 123-128

  Balen, Adam H ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Gonadotrophin surge attenuating factor; Inhibin; Luteinizing hormone; Polycystic ovary syndrome

Indexed keywords

GONADORELIN; GONADOTROPIN; INHIBIN; LUTEINIZING HORMONE;

CONFERENCE PAPER; FEEDBACK SYSTEM; FEMALE; GONADORELIN RELEASE; GONADOTROPIN RELEASE; HORMONE SENSITIVITY; HUMAN; HYPERINSULINEMIA; HYPOPHYSIS; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; LUTEINIZING HORMONE RELEASE; OVARY; OVARY POLYCYSTIC DISEASE; PULSATILE HORMONE RELEASE;

FEMALE; FERTILIZATION IN VITRO; GONADORELIN; HUMAN; HYPOTHALAMUS; INSULIN; LUTEINIZING HORMONE; OVARY; PITUITARY GLAND; POLYCYSTIC OVARY SYNDROME;

EID: 0027504772     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/8.suppl_2.123     Document Type: Article

References (61)

1. Abdulwahid N.A., Adams J., Van der Spuy Z.M. and Jacobs H.S. (1985) Gonadotrophin control of follicular development. Clin. Endocrinol., 23, 613-626.
2. Ackland J.F., Schwartz N.B., Mayo K.E. and Dodson R.E. (1992) Nonsteroidal signals originating in the gonads. Physiol. Rev., 72, 731-787.
3. Antilla L., Ding Y.-Q., Ruutiainen K., Erkkola R., Itjala K. and Huhtaniemi I. (1991) Clinical features and circulating gonadotropin, insulin and androgen interactions in women with polycystic ovarian disease. Fertil. Steril., 55, 1057-1061.
4. Baird D.T., Corker C.S., Davison D.W., Hunter W.M., Michie E.A. and Van Look P.F.A. (1977) Pituitary ovarian relationships in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 45, 798-809.
5. Balen A.H. and Jacobs H.S. (1991) Gonadotrophin surge attenuating factor: a missing link in the control of LH secretion? Clin. Endocrinol., 35, 399-402.
6. Balen A.H., Tan S.-L., MacDougall J. and Jacobs H.S. (1993) Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and decreased by pituitary densensitization with buserelin. Hum. Reprod., 8, 959-964.
7. Barbarino A. and De Marinis L. (1980) Estrogen induction of luteinizing hormone release in castrated adult human males. J. Clin. Endocrinol. Metab., 51, 280-286.
8. Barnes R. and Lobo R. (1985) Central opioid activity in the polycystic ovary syndrome with and without dopaminergic modulation. J. Clin. Endocrinol. Metab., 61, 779.
9. Buckler H.M., McLachlan R.I., MacLachlan V.B., Healy D.L. and Burger H.G. (1988) Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone-releasing hormone agonist and exogenous gonadotrophin administration. J. Clin. Endocrinol. Metab., 66, 798-803.
10. Burger H.G. (1992) Inhibin: review. Reprod. Med. Rev., 1, 1-20.
11. Burger H.G. and Igarashi M. (1988) Inhibin—definition and nomenclature. J. Clin. Endocrinol. Metab., 66, 885-886.
12. Burger C.W., Korsen T., Van Kessel H., Van Dop D.A., Caron F.J.M. and Schoemaker J. (1985) Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non PCOD secondary amenorrhoea. J. Clin. Endocrinol. Metab., 61, 1126-1132.
13. Chang R.J., Mandfdel F.P., Lu J.K. and Judd H.L. (1982) Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 54, 490-494.
14. Conway G.S., Honour J.W. and Jacobs H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol., 30, 459-470.
15. Conway G.S., Clark P.M.S. and Wong D. (1993) Hyperinsulinaemia in the polycystic ovary syndrome with specific immunoradiometric assay for insulin. Clin. Endocrinol., 38, 219-222.
16. Cumming D.C., Reid R.L., Quigley M.E., Rebar R.W. and Yen S.S.Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin. Endocrinol., 20, 643-648.
17. Danforth D.R., Sinosich M.J., Anderson T.L., Cheng C.Y., Bardin C.W. and Hodgen G.D. (1987) Identification of gonadotrophin surge inhibiting factor in follicular fluid and its differentiation from inhibin. Biol. Reprod., 37, 1075-1082.
18. Danforth D.R., Elkind-Hirsch K., Hodgen G. (1990) In-vivo and in- vitro modulation of GnRH metabolism by estradiol and progesterone. Endocrinology, 127, 319-324.
19. Dekel N., Galiani D. and Aberdam E. (1990) Regulation of rat oocyte maturation: involvement of protein kinases. In Bavister.B.D., Cummins, J. and Roldan, E.R.S. (eds), Fertilisation in Mammals. Serono Symposia, Norwell, USA, pp. 17-24.
20. DeVane G.M., Czekalab N.M., Judd H.L. and Yen S.S.C. (1974) Circulating gonadotropins, estragens and androgens in polycystic ovarian disease. Am. J. Obstet. Gynecol., 38, 476-481.
21. Drouin J., Lavoie M. and Labrie F. (1978) Effect of gonadal steroids on the luteinising hormone follicle stimulating hormone response to 8-bromo-adenosine-3', 5'-monophosphate in anterior pituitary cells in culture. Endocrinology, 102, 358-364.
22. Fauser B.C.J.M., Pache T.D., Lamberts W.J., Hop W.C.J., de Jong F.H. and Dahl K.D. (1991) Serum bioactive and immunoreactive luteinising hormone and follicle stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovary disease. J. Clin. Endocrinol. Metab., 73, 811-817.
23. Fauser B.C.J.M., Pache T.D., Hop W.C.J., de Jong F.H. and Dahl K.D. (1992) The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates. Clin. Endocrinol., 37, 445-452.
24. Ferraretti A.P., Garcia J.E., Acosta A.A. and Jones G.S. (1983) Serum LH during ovulation induction with human menopausal gonadotrophin for in vitro fertilisation in normally menstruating women. Fertil. Steril., 40, 742-747.
25. Fowler R.E., Edwards R.G., Walters D.E., Chan S.T.H. and Steptoe P.C. (1978) Steroidogenesis in preovulatory follicles of patients given human menopausal and chorionic gonadotrophins as judged by the radioimmunoassay of steroids in follicular fluid. J. Endocrinol., 77, 161-169.
26. Gadir A.A., Khatim M.S., Mowafi R.S., Alnaser H.M.I., Alzaid H.G.N. and Shaw R.W. (1990) Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization. Clin. Endocrinol., 32, 749-754.
27. Giguere V., Lefebvre F.-A. and Labrie F. (1981) Androgens decrease LHRH binding sites in rat anterior pituitary cells in culture. Endocrinology, 108, 350-352.
28. Goh H.H. and Ratnam S.S. (1990) The gonadotrophin surge in humans: Its mechanism and role in ovulatory function—A review. Ann. Acad. Med., 19, 524-529.
29. Griffiths E.C., Hooper K.C., Jeffcoate S.L. and Holland D.T. (1975) The effects of gonadectomy and gonadal steroids on the activity of hypothalamic peptidases inactivating luteinizing hormone-releasing hormone (LHRH). Brain Res., 88, 384.
30. Homburg R., Armar N.A., Eshel A., Adams J. and Jacobsn H.S. (1988) Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. Med. J., 297, 1024-1026.
31. Howies C.M., Macnamee M.C., Edwards R.G., Goswamy R. and Steptoe P.C. (1986) Effect of high tonic levels of luteinizing hormone on outcome of in-vitro fertilisation. Lancet, i, 521-522.
32. Hsueh A.J.W., Erickson G.F. and Yen S.S.C. (1979) The sensitizing effect of estrogens and catechol estrogen on cultured pituitary cells to LHRH: Its antagonism by progestins. Endocrinology, 104, 807-813.
33. Jeffcoate S.L. (1993) Analytical and clinical significance of peptide hormone heterogeneity with particular reference to growth hormone and luteinising hormone in serum. Clin. Endocrinol., 38, 113-121.
34. Karsch F.J. (1987) Central actions of ovarian steroids in the feedback regulation of pulsatile secretion of luteinising hormone. Annu. Rev. Physiol., 49, 365-382.
35. Kazer R.R., Kessel B. and Yen S.S. (1987) Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 65, 233-236.
36. Lobo R.A., Kletzky O.A., Campeau J. and diZerega G. (1983) Elevated bioactive luteinising hormone in women with polycystic ovary syndrome. Fertil. Steril., 39, 674-679.
37. Lobo R.A., Shoupe D., Chang S.P. and Campeau J. (1984) The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome. Am. J. Obstet. Gynecol., 148, 423-428.
38. Mason A.J., Hayflick J.S., Ling N., Esch F., Ueno N., Ying S.Y., Guillemin R., Nial H. and Seeburg P. (1985) Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-B. Nature, 318, 659-663.
39. Matteri R.L., Djiershke D.J., Bridson W.E., Rhutasel N.S. and Robinson J. A. (1990) Regulation of the biopotency of primate LH by GnRH in-vitro and in-vivo. Biol. Reprod., 43, 1045-1049.
40. Messinis I.E. and Templeton A. (1989) Pituitary response to exogenous LHRH in superovulated women. J. Reprod. Fertil., 87, 633-639.
41. Messinis I.E., Templeton A. and Baird D.T. (1985) Endogenous luteinising hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotrophin. J. Clin. Endocrinol. Metab., 61, 1076-1080.
42. Murdoch A.P., Diggle P.J., Dunlop W. and Kendall-Taylor P. (1985) Determination of the frequency of pulsatile luteinising hormone secretion by time series analysis. Clin. Endocrinol., 22, 341-346.
43. Murdoch A.P., Diggle P.J., White M.C., Kendall-Taylor P. and Dunlop W. (1989) LH in polycystic ovary syndrome: reproducibility and pulsatile secretion. J. Endocrinol., 121, 185-191.
44. Plosker S.M., Marshall L.A., Martin M.C. and Jaffe R.B. (1990) Opioid, catecholamine and steroid interaction in prolactin and gonadotropin regulation. Obstet. Gynecol., 45, 441-453.
45. Punnonen R., Ashom R., Vilja P., Heinonen P K., Kujansuu E. and Tuohimaa P. (1988) Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil. Steril., 49,479-482.
46. Quigley M., Rakoff J. and Yen S.S.C. (1981) Increased luteinising hormone sensitivity to dopamine inhibition in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 52, 231.
47. Rasmussen D.D., Liu J.H., Wolf P.L. and Yen S.S. (1986) Gonadotrophin-releasing hormone neurosecretion in the human hypothalamus: in vitro regulation by dopamine. J. Clin. Endocrinol. Metab., 62, 479-483.
48. Rebar R.H.L., Yen S.C.C., Rakoff J., Vandenberg G. and Naftolin F. (1976) Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest., 57, 1320-1329.
49. Regan L., Owen EJ. and Jacobs H.S. (1990) Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet, 336, 1141-1144.
50. Robertson D.M., Foulds L.M., Leversha L., Morgan F.J., Hearn M.T.W., Burger H.G., Wettenhall R.E.H. and de Kretser D.M.Isolation of inhibin from bovine follicular fluid. Biochem. Biophys. Res. Common., 126, 220-226.
51. Rosenfield R.L., Barnes R.B., Cara J.F. and Lucky A.W. (1990) Dysregulation of cytochrome P450c 17-alpha as the cause of polycystic ovarian syndrome. Fértil. Steril., 53, 785-791.
52. Rossmanith W., Mortola J. and Yen S.S.C. (1988) Role of endogenous peptides in the initiation of the mid-cycle luteinising surge in normal cycling women. J. Clin. Endocrinol. Metab., 67, 695.
53. Rossmanith W.G., Keckstein J., Spatzier K. and Lauritzen C. (1991) The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease. Clin. Endocrinol., 34, 223-230.
54. Sagle M., Kiddy D., Mason H.D., Dobriansky D., Poison D.W. and Franks S. (1987) Evidence for normal hypothalamic regulation of LH in ovulatory women with the polycystic ovary syndrome. In Rolland.R., Heineman.M.J. et al. (eds), Neuroendocrinology of Reproduction. Excerpta Medica, Amsterdam.
55. Sopelak V.M. and Hodgen G.D. (1984) Blockade of the estrogen- induced luteinising hormone surge in monkeys: a nonsteroidal, antigenic factor in porcine follicular fluid. Fértil. Steril., 41, 108-113.
56. Spinder T., Spijkstra J.J., van den Tweel J.G., Burger C.W., van Kessel H., Hompes P.G.A. and Gooren L.J.G. (1989) The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J. Clin. Endocrinol. Metab., 69, 151-157.
57. Sprangers S.A., Brenner R.M. and Bethea C.L. (1989) Estrogen and progesterone receptor immunocytochemistry in lactotropes versus gonadotropes of monkey pituitary cell cultures. Endocrinology, 124, 1462-1470.
58. Stanger J.D. and Yovich J.L. (1985) Reduced in-vitro fertilisation of human oocyte from patients with raised basal luteinising hormone levels during the follicular phase. Br. J. Obstet. Gynaecol., 92, 385-393.
59. Venturoli S., Porcu E., Fabbri R., Magrini O., Gammi L., Paradisi R., Forcacci M., Bolzani R. and Flamigni C. (1988) Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone and LH circadian variations in polycystic ovary syndrome. Clin. Endocrinol., 28, 93-107.
60. Verma S., Monks N., Turner K., Hooper M., Kumar A. and Lenton E. (1991) Influence of elevated LH during follicular phase on fertility as assessed in a natural IVF programme. 7th Annual Meeting of the ESHRE and the 7th World Congress on IVF and Assisted Procreation, Paris, July 1991. Hum. Reprod., 6 (Suppl.l), 60.
61. Wamt E.L., Williams B.E., Cowan B.D., Lynch A., Lemer S.P. and Hodgen G.D. (1981) Pulsatile pituitary gonadotropin secretion during maturation of the dominant follicle in monkeys: estrogen positive feedback enhances the biological activity of LH. Endocrinology, 109, 2270-2272.